Field trials of methisazone as a prophylactic agent against smallpox.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 4941154)

Published in Am J Epidemiol on November 01, 1971

Authors

G G Heiner, N Fatima, P K Russell, A T Haase, N Ahmad, N Mohammed, D B Thomas, T M Mack, M M Khan, G L Knatterud, R L Anthony, F R McCrumb

Articles by these authors

(truncated to the top 100)

Tularemia as a biological weapon: medical and public health management. JAMA (2001) 13.23

The introduction of jet injection mass vaccination into the national smallpox eradication program of Brazil. Trop Geogr Med (1971) 11.37

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (1993) 11.15

Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27

Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (2000) 8.45

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.96

Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci U S A (1978) 7.95

Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA (1999) 7.06

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61

Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40

Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27

The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J Virol (1988) 5.94

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83

A plaque reduction test for dengue virus neutralizing antibodies. J Immunol (1967) 5.78

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science (1997) 5.55

Pathogenesis of lentivirus infections. Nature (1986) 4.61

A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes (1970) 4.57

A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum (1992) 4.50

Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA (1991) 4.49

High constant incidence in twins and other relatives of women with breast cancer. Nat Genet (2000) 4.03

Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64

Smallpox in Europe, 1950-1971. J Infect Dis (1972) 3.38

Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14

Flaviviridae. Intervirology (1985) 3.06

Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis (1998) 3.05

The slow infection caused by visna virus. Curr Top Microbiol Immunol (1975) 2.99

Estrogen-progestin replacement therapy and endometrial cancer. J Natl Cancer Inst (1997) 2.92

Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92

Slow persistent infection caused by visna virus: role of host restriction. Science (1977) 2.83

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci U S A (2001) 2.79

Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci U S A (1984) 2.73

Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun (1976) 2.67

Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci (1998) 2.65

The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64

Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis (2001) 2.63

Detection of additional antigenic determinants of hepatitis B antigen. J Immunol (1972) 2.57

Bunyaviridae. Intervirology (1980) 2.53

Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr (2000) 2.52

Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol (1991) 2.47

Visna DNA synthesis and the tempo of infection in vitro. Virology (1982) 2.47

Dengue virus identification by the plaque reduction neutralization test. J Immunol (1967) 2.45

Structural studies on human erythrocyte glycoproteins. Alkali-labile oligosaccharides. J Biol Chem (1969) 2.43

Comparison of recalled and validated oral contraceptive histories. Am J Epidemiol (1993) 2.42

Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1998) 2.39

Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39

Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing. Virology (1976) 2.32

Primary corneal graft failure. A national reporting system. Medical Advisory Board of the Eye Bank Association of America. Arch Ophthalmol (1995) 2.31

Green tea and skin. Arch Dermatol (2000) 2.29

A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25

Cancer surveillance program in Los Angeles County. Natl Cancer Inst Monogr (1977) 2.21

Thermodynamic quantities associated with the interaction of adenosine triphosphate with metal ions. J Am Chem Soc (1966) 2.20

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate (2000) 2.19

Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol (1999) 2.17

Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results. JAMA (1971) 2.17

DDT and related compounds and risk of pancreatic cancer. J Natl Cancer Inst (1992) 2.16

A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15

Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev (1999) 2.15

Job activity and colon cancer risk. Am J Epidemiol (1984) 2.15

An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. J Infect Dis (1975) 2.15

Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13

Admission and prevalence rates for psychiatric facilites in four register areas. Am J Public Health Nations Health (1966) 2.11

Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg (1996) 2.11

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A (1997) 2.11

Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature (1968) 2.10

Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. Science (1985) 2.09

Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05

Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation (1997) 2.04

The occurrence of autoantibodies in infectious mononucleosis. Clin Exp Immunol (1974) 2.00

Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics (1976) 2.00

Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99

Antibodies to membrane antigen(s) common to thymocytes and a subpopulation of lymphocytes in infectious-mononucleosis sera. Lancet (1972) 1.98

Gene expression in visna virus infection in sheep. Nature (1981) 1.98

Togaviridae. Intervirology (1985) 1.96

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation (1991) 1.96

Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst (1986) 1.95

Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis (1971) 1.95

Electric power, pineal function, and the risk of breast cancer. FASEB J (1992) 1.95

During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems. Cell Microbiol (2007) 1.94

Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure. J Virol (1990) 1.94

Hemorrhagic fever in Thailand; recent knowledge regarding etiology. Jpn J Med Sci Biol (1967) 1.94

Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J Immunol (1968) 1.92

Cutting edge: In situ tetramer staining of antigen-specific T cells in tissues. J Immunol (2000) 1.92

Swine influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and speculation. J Infect Dis (1977) 1.88

Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85

Antigenic variation in visna virus. Cell (1979) 1.81

The structural polypeptides of RNA slow viruses. Virology (1974) 1.81

Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg (1968) 1.80

Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci U S A (1993) 1.79

Replication of dengue-2 virus in cultured human lymphoblastoid cells and subpopulations of human peripheral leukocytes. J Immunol (1976) 1.79

Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med (1994) 1.78

Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet (1981) 1.77

Occupational exposure to electromagnetic fields and breast cancer in men. Am J Epidemiol (1991) 1.76

Blood volume determination in the mouse. J Physiol (1973) 1.72

Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci U S A (1999) 1.72

Radioimmune precipitation of group A arboviruses. J Immunol (1972) 1.71

Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993-1995. Int J Cancer (2000) 1.70

Immunoprecipitation analysis of soluble complement-fixing antigens of dengue viruses. J Immunol (1970) 1.69

Change involving a viral membrane glycoprotein during morphogenesis of group B arboviruses. Virology (1972) 1.69